Lopreeza Tablet, Film Coated
Product Images NDC 69238-1252

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Lopreeza (NDC 69238-1252). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Estradiol Chem Structure (Lopreeza Estradiol Norethindrone Acetate Tablets 1)

FDA Label Image

Directions (Lopreeza Estradiol Norethindrone Acetate Tablets 10)

Directions (Lopreeza Estradiol Norethindrone Acetate Tablets 10)
This is a set of instructions on how to use Lopreeza (a medication). It includes steps for taking the first tablet, setting a day reminder, and taking the tablet every day using the dispenser.*
FDA Label Image

Ld Dial (Lopreeza Estradiol Norethindrone Acetate Tablets 11)

Ld Dial (Lopreeza Estradiol Norethindrone Acetate Tablets 11)
This appears to be information related to a medication called Lopreeza, consisting of tablets containing 0.5 mg of estradiol and 0.1 mg of norethindrone acetate per tablet. The product is distributed by Amneal Pharmaceuticals and is available only by prescription. The lot number and expiry date of the medication are also provided.*
FDA Label Image

Ld Carton (Lopreeza Estradiol Norethindrone Acetate Tablets 12)

Ld Carton (Lopreeza Estradiol Norethindrone Acetate Tablets 12)
Lopreeza is a medication in tablet form and each tablet contains estradiol 0.5mg and norethindrone acetate 0.1 mg. It is suggested to store it in a dry and light-protected area, between 20°C - 25°C (68°F - 77°F), and excursion is allowed up to 15°C - 30°C (59°F - 86°F). The manufacturer is Novo Nordisk A/S, and the product is distributed by Amneal Pharmaceuticals. The package is not child-resistant. The product includes boxed warning and additional information for the patient. The text also contains a reference number - NDC 69238-1252-6 and an expiry/Lot number, but it is not possible to read the expiry or lot number.*
FDA Label Image

Hd Dial (Lopreeza Estradiol Norethindrone Acetate Tablets 13)

Hd Dial (Lopreeza Estradiol Norethindrone Acetate Tablets 13)
This is a description of Lopreeza, a medication containing estradiol and norethindrone acetate. Each package contains 28 tablets, with each tablet containing 1 mg of estradiol and 0.5 mg of norethindrone acetate. The medication is only available by prescription and is distributed by Amneal Pharmaceuticals. The lot and expiry information is provided on the packaging.*
FDA Label Image

Hd Carton (Lopreeza Estradiol Norethindrone Acetate Tablets 14)

FDA Label Image

Noreth Acetate Chem Structure (Lopreeza Estradiol Norethindrone Acetate Tablets 2)

FDA Label Image

Figure 1a (Lopreeza Estradiol Norethindrone Acetate Tablets 3)

FDA Label Image

Figure 1b (Lopreeza Estradiol Norethindrone Acetate Tablets 4)

FDA Label Image

Figure2 (Lopreeza Estradiol Norethindrone Acetate Tablets 5)

FDA Label Image

Figure 3 (Lopreeza Estradiol Norethindrone Acetate Tablets 6)

FDA Label Image

Figure 4 (Lopreeza Estradiol Norethindrone Acetate Tablets 7)

FDA Label Image

Figure 5 (Lopreeza Estradiol Norethindrone Acetate Tablets 8)

Figure 5 (Lopreeza Estradiol Norethindrone Acetate Tablets 8)
This text indicates that the percentage of women is 100%, meaning that all individuals in the group being referred to are female.*
FDA Label Image

Figure6 (Lopreeza Estradiol Norethindrone Acetate Tablets 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.